Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Net Margin

IONIS PHARMACEUTICALS INC Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • IONIS PHARMACEUTICALS INC net margin for the quarter ending 2017-12-31 was -1.69%, a 105.22% decline year-over-year.
  • IONIS PHARMACEUTICALS INC net margin for the quarter ending 2017-09-30 was -2.16%, a 132.59% decline year-over-year.
  • IONIS PHARMACEUTICALS INC net margin for the quarter ending 2017-06-30 was -2.96%, a change of 144.83% year-over-year.
  • IONIS PHARMACEUTICALS INC net margin for the quarter ending 2017-03-31 was 8.13%, a change of 178.75% year-over-year.
  • IONIS PHARMACEUTICALS INC net margin for fiscal 2025 was -40.41%, a change of 23.96% from fiscal 2024.
  • IONIS PHARMACEUTICALS INC net margin for fiscal 2024 was -64.37%, a change of -17.87% from fiscal 2023.
  • IONIS PHARMACEUTICALS INC net margin for fiscal 2023 was -46.50%, a change of -0.58% from fiscal 2022.
  • IONIS PHARMACEUTICALS INC net margin for fiscal 2022 was -45.92%, a change of -42.39% from fiscal 2021.
Available history
2009-06-30 to 2025-12-31
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2017-12-31-1.69%-$2.92M$172.3M
2017-09-30-2.16%-$2.61M$120.91M
2017-06-30-2.96%-$3.09M$104.15M
2017-03-318.13%$8.96M$110.3M
2016-12-3132.44%$52.02M$160.35M
2016-09-306.63%$7.35M$110.93M
2016-06-30-147.79%-$56.86M$38.47M
2016-03-31-170.63%-$62.92M$36.87M
2015-12-31-138.52%-$71.43M$51.57M
2015-09-30-72.83%-$35.78M$49.12M
2015-06-3029.60%$35.65M$120.43M
2015-03-31-26.71%-$16.72M$62.58M
2014-12-3136.59%$31.05M$84.86M
2014-09-30-60.54%-$26.68M$44.06M
2014-06-30-21.17%-$12.08M$57.08M
2011-06-30-72.07%-$17.89M$24.82M
2011-03-31-94.55%-$19.99M$21.15M
2010-12-31-52.94%-$13.99M$26.42M
2010-09-30-43.51%-$12.45M$28.62M
2010-06-30-107.02%-$25.15M$23.5M
2010-03-31-32.27%-$9.66M$29.93M
2009-12-31-52.20%-$16.84M$32.26M
2009-09-30-43.26%-$11.58M$26.77M
2009-06-30-8.81%-$2.73M$30.99M

Annual Net Margin

DateNet MarginNet incomeRevenue
2025-12-31-40.41%-$381.39M$943.71M
2024-12-31-64.37%-$453.9M$705.14M
2023-12-31-46.50%-$366.29M$787.65M
2022-12-31-45.92%-$269.72M$587.37M
2021-12-31-3.53%-$28.6M$810.46M
2020-12-31-60.92%-$444.26M$729.26M
2019-12-3124.78%$278.14M$1.12B
2018-12-3145.65%$273.74M$599.67M
2017-12-310.07%$346,000.00$514.18M
2016-12-31-16.20%-$60.4M$372.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10